This is a preview of subscription content, log in via an institution to check access.
References
Institute for Clinical and Economic Review. ICER Posts Draft Scoping Document for the Assessment of Treatments for Duchenne Muscular Dystrophy. Internet Document : 11 Jan 2019. Available from: URL: https://icer-review.org/announcements/icer-posts-draft-scoping-document-for-the-assessment-of-treatments-for-duchenne-muscular-dystrophy/
Institute for Clinical and Economic Review. ICER to Assess Whether the Most Significant Prescription Drug Price Increases Are Supported by New Clinical Evidence. Internet Document : 17 Jan 2019. Available from: URL: https://icer-review.org/announcements/icer-to-assess-whether-the-most-significant-prescription-drug-price-increases-are-supported-by-new-clinical-evidence/
Rights and permissions
About this article
Cite this article
DMD treatments and drug price hikes under ICER's microscope. PharmacoEcon Outcomes News 820, 1 (2019). https://doi.org/10.1007/s40274-019-5580-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5580-8